Focus Partners Wealth’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Focus Partners Wealth’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Sell	2,510 -32	-1%	-$2.88K	﹤0.01%	2372
2026 Q1	$220K	Sell	2,542 -887	-26%	-$77.6K	﹤0.01%	2369
2025 Q4	$291K	Sell	3,429 -188	-5%	-$15K	﹤0.01%	2244
2025 Q3	$263K	Buy	3,617 +500	+16%	+$34.5K	﹤0.01%	1919
2025 Q2	$204K	Buy	3,117 +18	+0.6%	+$1.17K	﹤0.01%	1867
2025 Q1	$219K	Sell	3,099 -2,410	-44%	-$167K	﹤0.01%	1716
2024 Q4	$362K	Buy	+5,509	New	+$379K	﹤0.01%	1466

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

Focus Partners Wealth's IHE Position: Q2 2026 in Review

Focus Partners Wealth reduced its iShares US Pharmaceuticals ETF (IHE) stake by 1.3% in Q2 2026, selling an estimated $2.88K and leaving 2,510 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Focus Partners Wealth first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. The position peaked at $362K in Q4 2024. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Focus Partners Wealth held 2,510 shares of iShares US Pharmaceuticals ETF worth $249K as of Q2 2026.
Focus Partners Wealth sold 32 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $2.88K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2372 holding.
Focus Partners Wealth first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
Focus Partners Wealth's iShares US Pharmaceuticals ETF position peaked at $362K in Q4 2024.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.